| Dr Kevin J Mace, MD | |
|
1 Stadium Drive, Morgantown, WV 26506 | |
| (304) 598-4800 | |
| (304) 293-6963 |
| Full Name | Dr Kevin J Mace |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 1 Stadium Drive, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629151436 | NPI | - | NPPES |
| 3810001052 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 21540 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Hospital Center | Bridgeport, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
Dr Dilys Morgan who led the group on behalf of the Agency said; "It is reassuring that the cause of illness in the heifer has been identified. Enteroviruses are a common cause of illness in both animals and humans, however they do not usually cross between species.
Nine institutions from eight countries participated in the inaugural meeting of the International Specialty Orthopaedic Collaboratorium (ISOC), hosted by New York City's Hospital for Special Surgery.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that data from a recent clinical trial of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
› Verified 3 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
Dr Dilys Morgan who led the group on behalf of the Agency said; "It is reassuring that the cause of illness in the heifer has been identified. Enteroviruses are a common cause of illness in both animals and humans, however they do not usually cross between species.
Nine institutions from eight countries participated in the inaugural meeting of the International Specialty Orthopaedic Collaboratorium (ISOC), hosted by New York City's Hospital for Special Surgery.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that data from a recent clinical trial of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin J Mace, MD Po Box 897, Morgantown, WV 26507-0897 Ph: (304) 293-7401 | Dr Kevin J Mace, MD 1 Stadium Drive, Morgantown, WV 26506 Ph: (304) 598-4800 |
News Archive
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
Dr Dilys Morgan who led the group on behalf of the Agency said; "It is reassuring that the cause of illness in the heifer has been identified. Enteroviruses are a common cause of illness in both animals and humans, however they do not usually cross between species.
Nine institutions from eight countries participated in the inaugural meeting of the International Specialty Orthopaedic Collaboratorium (ISOC), hosted by New York City's Hospital for Special Surgery.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that data from a recent clinical trial of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Oncolytics Biotech Inc. announced today that it has completed enrollment in the first, 80 patient stage of its Phase III clinical trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers (REO 018).
› Verified 3 days ago
Dr. Nicole Lee Dorinzi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-216-0980 | |
Kevin J Blankenship, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Wharf St, Suite 100, Morgantown, WV 26501 Phone: 304-291-3627 Fax: 304-598-3630 | |
Dr. Joseph Michael Hartzog, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Venture Dr, Morgantown, WV 26508 Phone: 304-291-5533 Fax: 304-291-5548 | |
Dr. Christopher Edwards, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1200 | |
Dr. John Harold Marsh, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Emergency Department, Morgantown, WV 26505 Phone: 304-598-1200 | |
Matthew Kersteter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-293-7215 Fax: 304-293-6702 | |
Dr. Jack F Ditty Iii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Stadium Drive, Morgantown, WV 26505 Phone: 304-598-4000 Fax: 304-293-6963 |